2020-2021 Cancer Communications Committee Disclosures All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Name EMAIL Committee Employment Leadership Stock and Other Honoraria Consulting or Advisory Speakers' Bureau Research Funding Patents, Royalties, Other Expert Testimony Travel, Other Relationship (OPTIONAL) (OPTIONAL) Open Member Status Ownership Interests Role Intellectual Property Accommodations, Uncompensated Payments Link Expenses Relationships

Neeraj Agarwal [email protected] Active Astellas Pharma Active Biotech (Inst) Astellas Pharma (Inst) AstraZeneca AstraZeneca (Inst) AstraZeneca Bavarian Nordic (Inst) AVEO (Inst) Bayer BN ImmunoTherapeutics Bristol-Myers Squibb (Inst) Calithera Biosciences Bristol-Myers Squibb (Inst) Eisai Calithera Biosciences EMD Serono (Inst) Exelixis Celldex (Inst) Foundation Medicine Eisai (Inst) Foundation One Inc Exelixis (Inst) Genentech (Inst) Janssen Oncology GlaxoSmithKline (Inst) Lilly Immunomedics (Inst) Lilly Janssen (Inst) lily Merck (Inst) Medivation/Astellas Newlink Genetics (Inst) MEI Pharma (Inst) Merck (Inst) Nektar Prometheus (Inst) Novartis Rexahn Pharmaceuticals Pfizer (Inst) Pfizer Sanofi (Inst) Pharmacyclics Takeda (Inst) Seattle Genetics TRACON Pharma (Inst)

Muhammad S. Beg muhammad.beg@utsouthwestern. Active Array BioPharma Agios (Inst) edu AstraZeneca/MedImmune ArQule (Inst) Cancer Commons AstraZeneca/MedImmune Ipsen (Inst) Legend Biotech Bristol-Myers Squibb (Inst) CASI Pharmaceuticals (Inst) Celgene (Inst) Five Prime Therapeutics (Inst) Genentech (Inst) Immunesensor (Inst) MedImmune (Inst) Merck Serono (Inst) Sillajen (Inst) Tolero Pharmaceuticals (Inst)

Suzanne Cole [email protected] Active Exelixis (Inst) Merck Sharp & Dohme (Inst) Robert Dreicer [email protected] Active Astellas Pharma Bristol-Myers Squibb (Inst) Bayer Exelixis (Inst) Eisai Novartis (Inst) EMD Serono Seattle Genetics (Inst) Infinity Merck Myovant Pfizer Pfizer/Astellas Propella Tavanta Veru Cathy Eng [email protected] Active Array BioPharma Bayer Schering Pharma Foundation of Medicine Natera

Genetech Sandoz AstraZeneca Julie R. Gralow julie.gralowasco.org Active Immunomedics Melissa M. Hudson [email protected] Active Oncology Research Information Exchange Network Princess Máxima Center

Randall J. Kimple [email protected] Active Galera Therapeutics Guidepoint Global #Patent licensed through International Journal of Mele Associates the Univ of North Carolina. Radiation Oncology (I) Biology and Physics

#Patent licensed through the Wisconsin Alumni Research Fund (I)

#Patent for device to measure tumors Miriam Knoll [email protected] Active AstraZeneca Merry Jennifer Markham [email protected] Active GSK Aduro Biotech (Inst) Astra Zeneca (Inst) Lilly (Inst) Novartis (Inst) Tesaro (Inst) VBL Therapeutics (Inst) Jane L. Meisel [email protected] Active Medscape Clovis Oncology Pfizer Pfizer Total Health Eli Lilly Seattle Genetics Puma Conferencing Novartis Total Health Conferencing Pfizer Puma Biotechnology Timothy J. Moynihan [email protected] Active Rita Nanda [email protected] Active Aduro Abbvie (Inst) G1 Therapeutics du Athenex AstraZeneca (Inst) Celgene (Inst) Genentech/Roche Corcept Therapeutics Immunomedics (Inst) Ionis Genentech/Roche (Inst) Macrogenics Immunomedics (Inst) Merck Merck (Inst) Pfizer Odonate Therapeutics Seattle Genetics (Inst) Pfizer (Inst) Seattle Genetics (Inst)

Olatoyosi Odenike [email protected]. Active Abbvie Abbvie (Inst) edu Celgene Agios (Inst) Impact Biomedicines Aprea AB (Inst) Novartis Astex Pharmaceuticals (Inst) AstraZeneca (Inst) Celgene (Inst) CTI BioPharma Corp (Inst) Incyte (Inst) Janssen Oncology (Inst) Kartos (Inst) NS Pharma (Inst) Oncothyrapy (Inst)

Nathan A. Pennell [email protected] Active Amgen Altor BioScience (Inst) AstraZeneca AstraZeneca (Inst) Boehringer Ingelheim Bristol-Myers Squibb (Inst) Bristol-Myers Squibb Celgene (Inst) Cota Healthcare Genentech (Inst) G1 Therapeutics Heat Biologics (Inst) Genentech Jounce Therapeutics (Inst) Inivata Loxo (Inst) Janssen Oncology Merck (Inst) Lilly Mirati Therapeutics (Inst) Merck Pfizer (Inst) Mirati Therapeutics Spectrum Pharmaceuticals Pfizer (Inst) Viosera WindMIL (Inst) Xencor

Elizabeth R. Plimack [email protected] Active AstraZeneca Astellas Pharma (Inst) # U.S. Patent No.: Bristol-Myers Squibb AstraZeneca (Inst) 14/588,503, Filed Flatiron Bristol-Myers Squibb (Inst) 1/2/2015. (Inst) Genentech/Roche Genentech/Roche (Inst) Infinity Pharmaceuticals Merck Sharp & Dohme Janssen (Inst) MEI Pharma Pfizer (Inst) Merck Pfizer Seattle Genetics

Sonali M. Smith [email protected]. Active Abbvie/Genentech Acerta Karyopharm Therapeutics edu Bayer Pharma/AstraZeneca Janssen Oncology Celgene Karyopharm Therapeutics Forty Seven Kite Pharma Novartis Seattle Genetics Pharmacyclics/Janssen TG Therapeutics Portola Pharmaceuticals TG Therapeutics

Corey W. Speers [email protected] Active PFS Genomics #Compositions and PFS Genomics Methods for the Analysis of Radiosensitivity, UM- 33550/US-1, Coinventor, Submitted on 09/2013

#Methods and Genomic Classifiers for Prognosis of Breast Cancer and Predicting Benefit from Adjuvant Radiotherapy, Application No. 61/205,279, Co- inventor, Submitted on John W. Sweetenham Robert G. Uzzo [email protected] Active Amgen Janssen Oncology Novartis Genentech/Roche Pfizer UroGen Pharmaceutical